These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 17688988)

  • 1. Differential effects of spinal 5-HT1A receptor activation and 5-HT2A/2C receptor desensitization by chronic haloperidol.
    Gajendiran M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1449-55. PubMed ID: 17688988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evidence for serotonin 5-HT2C receptor-mediated long-lasting excitability of lumbar spinal reflex and its functional interaction with 5-HT1A receptor in the mammalian spinal cord.
    Gajendiran M
    Brain Res Bull; 2008 Mar; 75(5):674-80. PubMed ID: 18355645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of (R)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on the monosynaptic spinal reflex in rats.
    Honda M; Ono H
    Eur J Pharmacol; 1999 Jun; 373(2-3):171-9. PubMed ID: 10414436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of serotonergic drugs on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum].
    Ishikane T
    Hokkaido Igaku Zasshi; 1998 Sep; 73(5):441-9. PubMed ID: 9846274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 8-OH-DPAT, a 5-HT1A receptor agonist, and DOI, a 5-HT2A/2C agonist, on monosynaptic transmission in spinalized rats.
    Hasegawa Y; Ono H
    Brain Res; 1996 Oct; 738(1):158-61. PubMed ID: 8949941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
    Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2001 Sep; 428(1):81-6. PubMed ID: 11779040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of extensor excitability in the acute spinal cat by the 5-HT2 agonist DOI.
    Miller JF; Paul KD; Lee RH; Rymer WZ; Heckman CJ
    J Neurophysiol; 1996 Feb; 75(2):620-8. PubMed ID: 8714639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin 5-HT2 receptors induce a long-lasting facilitation of spinal reflexes independent of ionotropic receptor activity.
    Shay BL; Sawchuk M; Machacek DW; Hochman S
    J Neurophysiol; 2005 Oct; 94(4):2867-77. PubMed ID: 16033939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    Gardell LR; Vanover KE; Pounds L; Johnson RW; Barido R; Anderson GT; Veinbergs I; Dyssegaard A; Brunmark P; Tabatabaei A; Davis RE; Brann MR; Hacksell U; Bonhaus DW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):862-70. PubMed ID: 17519387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum.
    Ishikane T; Kusumi I; Matsubara R; Matsubara S; Koyama T
    Eur J Pharmacol; 1997 Feb; 321(2):163-9. PubMed ID: 9063684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: a double dissociation between dopamine D(2) and 5-HT(2A/2C) receptors.
    Zhao C; Li M
    Pharmacol Biochem Behav; 2009 Oct; 93(4):433-42. PubMed ID: 19539643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW; Ogilvie J; Houghton AK
    Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
    Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.
    Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of 5-HT 1A receptors increases the seizure threshold for picrotoxin in mice.
    Pericić D; Lazić J; Jazvinsćak Jembrek M; Svob Strac D
    Eur J Pharmacol; 2005 Dec; 527(1-3):105-10. PubMed ID: 16313900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
    Haleem DJ; Samad N; Haleem MA
    Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.